“Any student not intensively using AI, where permitted, is putting themselves at a significant disadvantage."

“We've provided a road map for individuals who have had this happen to them, said John Papianou, a partner at Montgomery McCracken Walker & Rhoads.

“These tests need to benefit the patients, not Harvard, Dana-Farber, Karolinska Institute and Mayo Clinic, they should benefit the patient, MMAS Research Solutions Architect Steve Trubow said.